METHODS
Bacteriophages. Bacteriophage-SP-50, obtained from Dr T. A. Trautner, was propagated on Bacillus subtilis w-23 ; bacteriophage K, obtained from Dr E. Asheshov, was propagated on Staphylococcus aureus 93 I 8 ; bacteriophages 52 A and 53, obtained from Mr G . Fenwick, were propagated on S. aureus strains 5 2~ and 3528 respectively.
The bacteriophages were re-isolated from single plaques and then propagated by the soft agar overlay method (Adams, 1959) . The bacteriophages were eluted from the plates with tryptic soy broth, filtered through a 0-45 nm Millipore filter and assayed in soft agar layers containing the propagating strain (2 x 1 0 ' bacteria/ml) grown for 5 h at 37 "C. The yield of plaque-forming units (p.f.u.) was between 5 x log/ml and 2 x Iolo/ml.
Antiserum. Rabbit antisera were prepared against the above bacteriophages and diluted so that under the test conditions over 99-9
Growth of bacteria. Bacteria were grown in NBS medium containing Oxoid Nutrient broth (2.5 ?<, w/v), sodium succinate (I %, w/v) and magnesium sulphate (0.01 M). Flasks (50 ml) containing this medium (25 ml) were inoculated with 0.2 rnl of an overnight culture, grown in the same medium, and incubated with aeration at 37 "C for 5 h when the bacilli attained log organisms/ml and the staphylococci 2 x 109/ml. Preliminary studies showed that this medium gave only a slight precipitate with Concanavalin A and did not inhibit the precipitation of glycogen by the lectin.
of the bacteriophages were inactivated.
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Concanavalin A . Water-soluble Concanavalin A was prepared by the method of Olson & Leiner (1967) . A stock solution was prepared containing Concanavalin A (I 8/10 ml buffer of the following composition: Na,HPO,, 7 g; KH2P04, 3 g; NaCl, 5 g; 0.1 M-M~SO,, 10 ml; 0.01 M-CaCl,, 10 nil; water, I 1). This stock solution was diluted into NBS medium before use.
Action of Concanavalin A on the binding of bacteriophages by Bacillus subtilis arid Staphylococcus aureus strains. Samples (0.1 ml containing approximately 7 x 107 bacteria) of the 5 h cultures suitably diluted in NBS medium at 37 "C were placed in plugged sterile tubes (16 x 150 mm) held in a water bath at 37 "C. Portions (0.1 ml) of Concanavalin A solution (0.5 % or I %) were added and the mixtures incubated at 37 "C for 5 min before being mixed with bacteriophage (0.1 ml containing approximately 7 x 105 p.f.u.). The mixture was incubated at 37 "C for a further 15 min before adding a sample (0.1 ml) to 9-9 ml of NBS medium at 37 "C. It was filtered through a 0.45 nm Millipore filter to remove bacteria and adsorbed bacteriophage and samples (0.1 ml) of the filtrate and of a tenfold dilution of the filtrate were assayed for plaque-forming units.
In control experiments bacteria were first incubated with 0-1 ml of Concanavalin A (I %) plus a-methyl glucoside (1 %, Sigma Chemical Co., London) or with NBS medium (OBI ml).
Further controls were set up to determine the number of bacteriophage and bacteria added to the mixtures. Plaque and colony counts were determined in duplicate, about 200 plaques or colonies were counted per plate except where more than 90 % of the bacteriophage were adsorbed. The experiments were repeated giving closely similar results. Under the above conditions incubation with Concanavalin A for 20min had no significant effect on the number of colonies formed, showing that agglutination was not detectable in this time at the low cell densities used.
The action on Concanavalin A on the infection of Bacillus subtilis and Staphylococcus aureus strains by bacteriophages. Samples (0.1 ml containing 7 x 107 bacteria) of 5 h cultures diluted into NBS medium at 37 "C were placed in sterile plugged tubes and mixed with samples (0.1 ml) of warm medium alone or with 0.5 % Concanavalin A plus and minus a-methyl glucoside as above. After incubation at 37 "C for 5 min, bacteriophage (0.1 ml containing approximately 106 p.f.u.) was added followed, after incubation for 5 min, by diluted antiserum (0.7 ml). After incubation for a further 5 min to inactive unadsorbed bacteriophage samples (0.1 ml) were serially diluted into NBS medium at 37 "C and duplicate portions (0.1 ml) were assayed for infectious centres by the soft agar overlay method.
In control experiments the numbers of bacteria and bacteriophage added to the mixtures were determined. Pre-incubation with Concanavalin A did not inactivate any of the phages studied and again none o f the bacteria were agglutinated by incubation with Concanavalin A under these conditions. Repeat experiments gave closely similar results although the values obtained were influenced by slight differences in the concentrations of bacteria and bacteriopage in separate experiments.
R E S U L T S A N D D I S C U S S I O N
All three strains of staphylococci adsorbed over 90 % of the bacteriophage originally present in the mixtures in 15 min of incubation. Pre-incubation with Concanavalin A had little effect on the adsorption of bacteriophage K by Staphylococcus aureus A I but markedly reduced the adsorption by S. aureus 3528 (Table I) . a-Methyl glucoside prevented this effect of Concanavalin A. The blocking is therefore due to the specific interaction of Concanavalin A with the sugar residues on the bacterial surface. These groups are almost certainly the a-N-acetyl-glucosaminyl substituents of the wall teichoic acid which is the only 
S . aweus H None
Bacillus subtilis w23
B. subtilis 3610
Incubation mixture 6 6 5 3 6 6 k 3 6 6 t 3 6 6 t 3 6 3 h 3 6 3 * 3 6 3 t 3 6 3 t 3 6 3 t 3 6 3 2 3 6 3 t 3 6 3 i 3 6 7 F 3 6 7 F 3 6 7 1 3 6 7 k 3 6 7 t 3 67+ 3 adsorbed known surface component which can intereact with Concanavalin A. This conclusion is strengthened by the failure of Concanavalin A to affect markedly the adsorption by strain A I , the wall teichoic acid of which is reported to contain only P-N-acetyl-glycosaminyl substituents. This organism may however contain a small proportion of a-linked N-acetyl- (Table I) and so was specifically due to the a-glucosyl substituents of the wall teichoic acid; in strain w-23 the wall teichoic acid contains only P-glucosyl substituents. Doyle & Birdsell (1972) have recently referred to
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Short communication unpublished results which show that Concanavalin A blocks the phage receptor sites in walls of B. subtilis 168, the teichoic acid of which is similar to that of strain 3610. The influence of Concanavalin A on bacteriophage infection was examined directly by neutralizing unadsorbed bacteriophage by the addition of antiserum and counting the infected organisms. In these experiments the bacteria were incubated with bacteriophage for only 5 min and the percentage of bacteriophage causing infection varied in different systems from 43 % to 92 %. On incubation with Bacillus subtilis strain 3610, 49 % of the added bacteriophage SP-50 gave rise to infective centres but this value was reduced to 3 % after pre-incubation with 0.25 % Concanavalin A, whereas after pre-incubation with Concanavalin A plus a-methyl glucoside 33 % of the added bacteriophage gave rise to infective centres. The corresponding values for strain w-23 were 49 %, 44 % and 44 % showing that Concanavalin A does not block infection in this organism. On incubation with Staphylococcus aureus 3528, 43 % of the added bacteriophage 53 gave infective centres. This value was reduced to 6 % on pre-incubation of the cells with Concanavalin A and to 32 % on incubation with Concanavalin A and a-methyl glucoside. With S. aureus H and bacteriophage 52A the corresponding values were 92%, 69% and 78%. Thus in the presence of Concanavalin A infectiori of strain 3528 by bacteriophage 53 is specifically inhibited by over 50% whereas infection of strain H is inhibited by less than 10 %. These results correlate well with the adsorption studies and both methods show that Concanavalin A specifically blocks adsorption of the bacteriophage to those organisms with wall teichoic acids in which the sugar substituents have the a-anomeric configuration but has no action on adsorption of phage to organisms in which these substituents have the /3-configuration. The results obtained with the three strains of S. aureus suggest that these procedures might form the basis for a correlation between the bacteriophage and serological typing of staphylococci. After removal of excess Concanavalin A, determination of the increase in infection or phage binding by cells coated with Concanavalin A might be used to study synthesis of new wall material.
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